Koch Industries’s Usana Health Sciences USNA Stock Holding History

Koch Industries’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,773	Closed	-$324K	–	624
2018 Q1	$324K	Buy	+3,773	New	+$292K	0.03%	606

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Koch Industries's USNA Position: Q2 2018 in Review

Koch Industries sold out of Usana Health Sciences (USNA) in Q2 2018, closing a stake of 3,773 shares — an estimated $324K sold.

Koch Industries first reported a position in USNA in Q1 2018 and held it in 1 quarter. The position peaked at $324K in Q1 2018. 189 funds tracked by Wall St. Rank hold USNA as of Q2 2018.

Koch Industries reported no remaining Usana Health Sciences position as of Q2 2018 after selling out during the quarter.
Koch Industries sold 3,773 Usana Health Sciences shares in Q2 2018, an estimated $324K.
Koch Industries first reported a position in Usana Health Sciences in Q1 2018 and held it in 1 quarter.
Koch Industries's Usana Health Sciences position peaked at $324K in Q1 2018.
189 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2018.

Based on Koch Industries's 13F filing for Q2 2018, filed 13 Aug 2018.